Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ASTELLAS PHARMA INC
12/08 ASTELLAS PHARMA : the Institute of Medical Science of the University of Tokyo, C..
12/07 ASTELLAS PHARMA : New Prostate Cancer Study Results from Astellas Pharma Describ..
12/07 ASTELLAS PHARMA : to Present New Data Exploring Gilteritinib in Newly Diagnosed ..
12/06 ASTELLAS PHARMA : takes up option to buy US mitochondrial drug discovery partner
12/06 ASTELLAS PHARMA : the Institute of Medical Science of the University of Tokyo, C..
12/05 ASTELLAS PHARMA : Announces Personnel Change
12/04 ASTELLAS PHARMA : Acquires Mitobridge Under Existing Collaboration
12/04 ASTELLAS PHARMA : BioCentury - Astellas acquires build-to-buy Mitobridge
12/01 ASTELLAS PHARMA : Submits a New Drug Application for Gonax 12-Week Extended-Rele..
12/01 ASTELLAS PHARMA : Announces Personnel Change(pdf 155KB)
12/01 ASTELLAS PHARMA : Acquires Mitobridge Under Existing Collaboration(pdf 359KB)
11/30 ASTELLAS PHARMA : Submits a New Drug Application for Gonax® 12-Week Extended-Rel..
11/29 ASTELLAS PHARMA : to Present New Data Exploring Gilteritinib in Newly Diagnosed ..
11/29 ASTELLAS PHARMA : to Present New Data Exploring Gilteritinib in Newly Diagnosed ..
11/28 ASTELLAS PHARMA : MSD and Astellas conclude co-promotion agreement in Japan for ..
11/21 ASTELLAS PHARMA : Oncology Awards $100,000 in C3 Prize Grants to Five Innovators..
11/21 ASTELLAS PHARMA : Reports from Astellas Pharma Provide New Insights into Rheumat..
11/16 ASTELLAS PHARMA : Findings from Astellas Pharma Yields New Findings on Medicinal..
11/16 SEATTLE GENETICS : and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin in..
11/16 ASTELLAS PHARMA : Study Findings on Medicinal Chemistry Are Outlined in Reports ..
11/16 FINDINGS IN THE AREA OF PHARMACOLOGY : A novel highly...
11/16 ASTELLAS PHARMA : Study Findings from H.E. Burton et al Broaden Understanding of..
11/16 ASTELLAS PHARMA : New Central Nervous System Agents Findings from Astellas Pharm..
11/09 ASTELLAS PHARMA : Partners with CNBC for its Global Branding Campaign
11/09 SEATTLE GENETICS : and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin in..
11/09 ASTELLAS PHARMA : and Seattle Genetics Initiate Phase 1b Trial of Enfortumab Ved..
11/03 ASTELLAS PHARMA : and FibroGen Announce Positive Topline Results from First Japa..
11/02 ASTELLAS PHARMA : Reports First Half FY2017 Financial Results Revises Fiscal Yea..
11/01 PROTEOSTASIS THERAPEUTICS : Focuses on Research and Development of CF Drug Candi..
11/01 ASTELLAS PHARMA INC. : - Extension of Agreement Pertaining to Sale of Telmisarta..
11/01 ASTELLAS PHARMA : Enters into a Screening Collaboration Agreement with MMV to Di..
11/01 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 121KB)
10/31 ASTELLAS PHARMA : Reports First Half FY2017 Financial Results, Revises Fiscal Ye..
10/31 ASTELLAS PHARMA : Positive Topline Results from First Japan Phase 3 Trial for Ro..
10/31 ASTELLAS PHARMA : Reports First Half FY2017 Financial Results, Revises Fiscal Ye..
10/30 ASTELLAS PHARMA : Partners with CNBC for its Global Branding Campaign (pdf 409KB..
10/30 ASTELLAS PHARMA : Enters into a Screening Collaboration Agreement with MMV to Di..
10/30 ASTELLAS PHARMA : Extension of Agreement Pertaining to Sale of Telmisartan (Mica..
10/26 ASTELLAS PHARMA : and Universal Cells, Inc. Announce a Collaboration Utilizing U..
10/26 ASTELLAS PHARMA : New Acute Myeloid Leukemia Findings from Astellas Pharma Discu..
10/24 ASTELLAS PHARMA : and Universal Cells Inc. Announce a Collaboration Utilizing Un..
10/20 ASTELLAS PHARMA : and Universal Cells, Inc. Announce a Collaboration Utilizing U..
10/19 ASTELLAS PHARMA : New Thrombosis Findings Has Been Reported by Investigators at ..
10/19 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/19 ASTELLAS PHARMA : and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedo..
10/18 ASTELLAS PHARMA : Enters into a New Collaborative Research Agreement with TB All..
10/13 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/12 ASTELLAS PHARMA : Patent Issued for Method for Treating Premature Ejaculation an..
10/12 ASTELLAS PHARMA : Patent Issued for Pharmaceutical Composition for Oral Administ..
10/12 SEATTLE GENETICS : Astellas and Seattle Genetics Initiate Pivotal Trial of Enfor..
10/12 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/12 Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct 'JOINUS,' a Ne..
10/11 SEATTLE GENETICS : and Astellas Initiate Pivotal Trial of Enfortumab Vedotin for..
10/11 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/11 ASTELLAS PHARMA : and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedo..
10/11 ASTELLAS PHARMA : Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct "JOINUS,"..
10/05 ASTELLAS PHARMA : Investigators from Astellas Pharma Release New Data on Genitou..
10/04 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
10/02 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 311KB)
10/02 ASTELLAS PHARMA : and TOA EIYO Announce Co-promotion Agreement for Kiklin® Capsu..
09/27 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
09/21 PFIZER : and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Tr..
09/15 PFIZER : Astellas Announce Positive Top-Line Results From Phase 3 Prosper Trial ..
09/15 ASTELLAS PHARMA : U.S. FDA Accepts for Review Astellas' Supplemental New Drug Ap..
09/14 ASTELLAS PHARMA : Announces Launch of 'Keep on Dancing' Sweepstakes
09/14 ASTELLAS PHARMA : Reports on Immunosuppressive Agents Findings from Astellas Pha..
09/13 ASTELLAS PHARMA : U.S. FDA Accepts for Review Astellas' Supplemental New Drug Ap..
09/11 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Addi..
09/08 ASTELLAS PHARMA : Announces Launch of 'Keep on Dancing' Sweepstakes
09/04 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
09/01 ASTELLAS PHARMA : Astella Announces Status of Acquisition of Own Shares (pdf 311..
08/31 ASTELLAS PHARMA : Researchers Submit Patent Application, "Pharmaceutical Composi..
08/31 ASTELLAS PHARMA : Farma Brasil Is Named One of the Best Companies to Work for in..
08/31 ASTELLAS PHARMA : First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteri..
08/30 ASTELLAS PHARMA : [email protected] Receives Approval for New 420mg Single-Dose Delivery ..
1  2  3  4  5  6  7  8Next
Financials ( JPY)
Sales 2018 1 287 B
EBIT 2018 220 B
Net income 2018 180 B
Finance 2018 380 B
Yield 2018 2,52%
P/E ratio 2018 16,05
P/E ratio 2019 14,89
EV / Sales 2018 2,00x
EV / Sales 2019 1,94x
Capitalization 2 958 B
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 548  JPY
Spread / Average Target 8,3%
EPS Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Chikashi Takeda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
Hironobu Yasuda Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-12.05%26 073
JOHNSON & JOHNSON21.23%377 698
NOVARTIS11.34%218 728
PFIZER9.48%213 036
ROCHE HOLDING LTD.6.19%208 877
MERCK AND COMPANY-7.68%151 559